journal article·2025-12-31Open access

An integrated in vitro and in silico approach to assess targeted cytotoxicity against MDA-MB-231 triple-negative breast cancer cells with Psidium guajava peel-derived chitosan nanoparticles

Vino Udappusamy, Rajan Thinagaran, Vijayakumar Mayakrishnan, Janani Balakarthikeyan, Priya Kannappan, Sameer Al-Ghamdi, Naif Abdurhman Alrudian, Mohammed Saad Alqahtani, Khalid Albasheer, Chandrabose Sureka, Mahmoud H. El-Bidawy, Nesreen Alsanousi, Sahar Gamil, Thiyagarajan Ramesh

Abstract

Triple-negative breast cancer (TNBC) is a significant global health issue, with high mortality rates. The chemotherapeutic drugs currently used for TNBC have significant side effects, impacting both normal and cancer cells. In this study, we investigated a potential use of fruit peel extract of Psidium guajava (PGP) encapsulated with chitosan nanoparticles (CSNPs) to combat TNBC. The synthesized PGP-CSNPs were characterized using UV–vis spectroscopy, Fourier transform infra-red (FTIR) spectroscopy, TEM and GC–MS. The maximum loading capacity and encapsulation efficacy of PGP-CSNPs were found to be 72.5 ± 0.49% and 92.9 ± 0.10%, respectively. Furthermore, in vitro cytotoxicity was assessed, and the IC50 value for PGP-CSNPs was 50.13 µg/mL. It was observed that PGP-CSNPs could induce apoptosis in MDA-MB-231 cells in dose-dependent manner. Furthermore, molecular docking was performed for bioactive compounds retrieved from PGP-CSNPs against human tumour suppressor proteins Bcl2, and results showed that the PGP-CSNPs had lower binding energy than cisplatin. This suggests that, the synthesized PGP-CSNPs have the potential to serve as a therapeutic agent for tackling TNBC. However, to validate its efficacy in human therapy, furthermore pre-clinical and clinical procedures should be examined, as this is an ongoing and significant step towards developing an effective and safe anticancer drug.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Psidium guajava Extracts and Applications · Essential Oils and Antimicrobial Activity · Phytochemistry Medicinal Plant Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biochemistry, PSG College of Arts and Science (Autonomous), Affiliated to Bharathiar University

Research Institute of Human Ecology, Yeungnam University

Department of Family and Community Medicine, College of Medicine, Prince Sattam Bin Abdulaziz University

Department of Internal Medicine, College of Medicine, Prince Sattam Bin Abdulaziz University

Department of Obstetrics and Gynecology, College of Medicine, Prince Sattam Bin Abdulaziz University

Department of Basic Medical Sciences, College of Medicine, Prince Sattam Bin Abdulaziz University

Department of Physiology, Faculty of Medicine, Cairo University

Department of Biochemistry, Faculty of Medicine, University of Khartoum

References (37)

Show source-provided references
1. 10.22034/APJCP.2018.19.8.222910.22034/APJCP.2018.19.8.2229 ↗
2. 10.4172/1948-5956.100025610.4172/1948-5956.1000256 ↗
3. 10.1039/978178801387110.1039/9781788013871 ↗
4. 10.1038/s41598-021-81701-x10.1038/s41598-021-81701-x ↗
5. 10.1016/j.biopha.2019.10959410.1016/j.biopha.2019.109594 ↗
6. 10.1016/j.foodchem.2019.03.14210.1016/j.foodchem.2019.03.142 ↗
7. 10.1016/j.foodchem.2017.07.12210.1016/j.foodchem.2017.07.122 ↗
8. Kaur M, Singh J, Mirza A. Pharmacological and medicinal properties of Psidium guajava: a review. Res J Chem Environ Sci. 2018;6(4):70–73.
9. 10.1016/j.jddst.2018.02.00110.1016/j.jddst.2018.02.001 ↗
10. 10.1016/j.sjbs.2021.07.07510.1016/j.sjbs.2021.07.075 ↗
11. 10.1155/2014/71045910.1155/2014/710459 ↗
12. 10.1016/j.colsurfa.2014.10.04010.1016/j.colsurfa.2014.10.040 ↗
13. 10.1016/j.carbpol.2013.02.03110.1016/j.carbpol.2013.02.031 ↗
14. 10.1038/s41598-018-22172-510.1038/s41598-018-22172-5 ↗
15. 10.1038/s41590-021-00975-510.1038/s41590-021-00975-5 ↗
16. 10.1016/j.cbi.2022.11028210.1016/j.cbi.2022.110282 ↗
17. 10.1002/path.473310.1002/path.4733 ↗
18. 10.3390/antiox1009133610.3390/antiox10091336 ↗
19. 10.1016/j.ijbiomac.2020.02.00710.1016/j.ijbiomac.2020.02.007 ↗
20. 10.3109/13880209.2015.106445110.3109/13880209.2015.1064451 ↗
21. 10.15171/ijb.156710.15171/ijb.1567 ↗
22. 10.5530/pj.2017.6.14910.5530/pj.2017.6.149 ↗
23. 10.1093/bioinformatics/16.8.74710.1093/bioinformatics/16.8.747 ↗
24. 10.3389/fphar.2022.96726210.3389/fphar.2022.967262 ↗
25. 10.1093/nar/28.1.23510.1093/nar/28.1.235 ↗
26. 10.1002/jcc.2125610.1002/jcc.21256 ↗
27. 10.3390/cryst1211155010.3390/cryst12111550 ↗
28. 10.1016/j.ijbiomac.2018.12.16110.1016/j.ijbiomac.2018.12.161 ↗
29. 10.1016/j.ijbiomac.2015.03.04510.1016/j.ijbiomac.2015.03.045 ↗
30. 10.1016/j.sjbs.2023.10387410.1016/j.sjbs.2023.103874 ↗
31. 10.1016/S2305-0500(15)30007-510.1016/S2305-0500(15)30007-5 ↗
32. 10.1016/j.jsps.2020.06.02010.1016/j.jsps.2020.06.020 ↗
33. 10.1016/j.fct.2016.12.03210.1016/j.fct.2016.12.032 ↗
34. 10.1016/j.jab.2016.02.00110.1016/j.jab.2016.02.001 ↗
35. 10.1016/j.jim.2015.04.02510.1016/j.jim.2015.04.025 ↗
36. 10.1007/s00210-021-02063-910.1007/s00210-021-02063-9 ↗
37. 10.1016/j.foodcont.2020.10778310.1016/j.foodcont.2020.107783 ↗